117 related articles for article (PubMed ID: 3568149)
41. Role of microtubules in the organization and localization of the Golgi apparatus.
Sandoval IV; Bonifacino JS; Klausner RD; Henkart M; Wehland J
J Cell Biol; 1984 Jul; 99(1 Pt 2):113s-118s. PubMed ID: 6146626
[TBL] [Abstract][Full Text] [Related]
42. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
43. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
Nair MP; Schwartz SA; Menon M
Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
[TBL] [Abstract][Full Text] [Related]
44. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit.
Hiserodt JC; Britvan L; Targan SR
J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352
[TBL] [Abstract][Full Text] [Related]
45. Release of natural killer cytotoxic factor (NKCF) from canine natural killer (NK) cells stimulated with cytoplasmic membrane of target cells.
Nakada Y; Tsukatani Y; Kosaka T; Miyamori M; Kuwabara M; Tanaka S; Koide F
J Vet Med Sci; 1995 Feb; 57(1):165-7. PubMed ID: 7756413
[TBL] [Abstract][Full Text] [Related]
46. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
47. Sera from patients with colon, breast and lung cancer induce resistance to lysis mediated by NK cytotoxic factors (NKCF).
Marubayashi M; Solana R; Ramirez R; Aranda E; Galan F; Peña J
Br J Cancer; 1991 Jun; 63(6):893-6. PubMed ID: 1906292
[TBL] [Abstract][Full Text] [Related]
48. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.
Degliantoni G; Murphy M; Kobayashi M; Francis MK; Perussia B; Trinchieri G
J Exp Med; 1985 Nov; 162(5):1512-30. PubMed ID: 3932579
[TBL] [Abstract][Full Text] [Related]
49. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
50. The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin/microtubule interplay.
Malorni W; Quaranta MG; Straface E; Falzano L; Fabbri A; Viora M; Fiorentini C
J Immunol; 2003 Oct; 171(8):4195-202. PubMed ID: 14530342
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
52. Interaction of microtubules with peroxisomes. Tubular and spherical peroxisomes in HepG2 cells and their alterations induced by microtubule-active drugs.
Schrader M; Burkhardt JK; Baumgart E; Lüers G; Spring H; Völkl A; Fahimi HD
Eur J Cell Biol; 1996 Jan; 69(1):24-35. PubMed ID: 8825021
[TBL] [Abstract][Full Text] [Related]
53. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.
Bonavida B; Wright SC
Adv Exp Med Biol; 1982; 146():379-88. PubMed ID: 7102465
[TBL] [Abstract][Full Text] [Related]
54. Human monocyte-mediated lysis of antibody-coated tumor cells: the role of the cytoskeleton in monocytes.
Espevik T
J Immunol; 1985 Mar; 134(3):2017-25. PubMed ID: 3881531
[TBL] [Abstract][Full Text] [Related]
55. Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.
Scott-Algara D; Vuillier F; Cayota A; Dighiero G
Clin Exp Immunol; 1992 Nov; 90(2):181-7. PubMed ID: 1424272
[TBL] [Abstract][Full Text] [Related]
56. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
57. Shape changes and chemokinesis of Walker 256 carcinosarcoma cells in response to colchicine, vinblastine, nocodazole and taxol.
Keller HU; Zimmermann A
Invasion Metastasis; 1986; 6(1):33-43. PubMed ID: 2867063
[TBL] [Abstract][Full Text] [Related]
58. Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network.
Malorni W; Straface E; Di Genova G; Fattorossi A; Rivabene R; Camponeschi B; Masella R; Viora M
Exp Cell Res; 1997 Nov; 236(2):436-45. PubMed ID: 9367628
[TBL] [Abstract][Full Text] [Related]
59. Multistage model of natural killer cell-mediated cytotoxicity involving NKCF as soluble cytotoxic mediators.
Bonavida B; Wright SC
Adv Cancer Res; 1987; 49():169-87. PubMed ID: 3314393
[No Abstract] [Full Text] [Related]
60. On the role of the nucleus in the structural organization of the cell: dispersion and rearrangement of the Golgi complex in cytoplasts treated with antimicrotubular drugs.
Moskalewski S; Thyberg J
J Submicrosc Cytol Pathol; 1988 Apr; 20(2):305-16. PubMed ID: 3395969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
